These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 26159259)

  • 1. Drug-Induced Liver Injury Is a Major Risk for New Drugs.
    Seeff LB
    Dig Dis; 2015; 33(4):458-63. PubMed ID: 26159259
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In silico modeling to optimize interpretation of liver safety biomarkers in clinical trials.
    Church RJ; Watkins PB
    Exp Biol Med (Maywood); 2018 Feb; 243(3):300-307. PubMed ID: 29096561
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Use of Hy's law and a new composite algorithm to predict acute liver failure in patients with drug-induced liver injury.
    Robles-Diaz M; Lucena MI; Kaplowitz N; Stephens C; Medina-Cáliz I; González-Jimenez A; Ulzurrun E; Gonzalez AF; Fernandez MC; Romero-Gómez M; Jimenez-Perez M; Bruguera M; Prieto M; Bessone F; Hernandez N; Arrese M; Andrade RJ; ; ;
    Gastroenterology; 2014 Jul; 147(1):109-118.e5. PubMed ID: 24704526
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diagnostic and predictive performance and standardized threshold of traditional biomarkers for drug-induced liver injury in rats.
    Tonomura Y; Kato Y; Hanafusa H; Morikawa Y; Matsuyama K; Uehara T; Ueno M; Torii M
    J Appl Toxicol; 2015 Feb; 35(2):165-72. PubMed ID: 25186495
    [TBL] [Abstract][Full Text] [Related]  

  • 5. DILI and drug development: a regulatory perspective.
    Avigan MI
    Semin Liver Dis; 2014 May; 34(2):215-26. PubMed ID: 24879985
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Art and Science of Diagnosing and Managing Drug-induced Liver Injury in 2015 and Beyond.
    Lewis JH
    Clin Gastroenterol Hepatol; 2015 Nov; 13(12):2173-89.e8. PubMed ID: 26116527
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Persistent liver biochemistry abnormalities are more common in older patients and those with cholestatic drug induced liver injury.
    Fontana RJ; Hayashi PH; Barnhart H; Kleiner DE; Reddy KR; Chalasani N; Lee WM; Stolz A; Phillips T; Serrano J; Watkins PB;
    Am J Gastroenterol; 2015 Oct; 110(10):1450-9. PubMed ID: 26346867
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Drug-induced liver injury in hospitalized patients with notably elevated alanine aminotransferase.
    Xu HM; Chen Y; Xu J; Zhou Q
    World J Gastroenterol; 2012 Nov; 18(41):5972-8. PubMed ID: 23139615
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of efficacy of folic acid and silymarin in the management of antiepileptic drug induced liver injury: a randomized clinical trial.
    Asgarshirazi M; Shariat M; Sheikh M
    Hepatobiliary Pancreat Dis Int; 2017 Jun; 16(3):296-302. PubMed ID: 28603098
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Specificity of transaminase activities in the prediction of drug-induced hepatotoxicity.
    Kobayashi A; Suzuki Y; Sugai S
    J Toxicol Sci; 2020; 45(9):515-537. PubMed ID: 32879252
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The transformation in biomarker detection and management of drug-induced liver injury.
    Church RJ; Watkins PB
    Liver Int; 2017 Nov; 37(11):1582-1590. PubMed ID: 28386997
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A systematic review of NSAIDs withdrawn from the market due to hepatotoxicity: lessons learned from the bromfenac experience.
    Goldkind L; Laine L
    Pharmacoepidemiol Drug Saf; 2006 Apr; 15(4):213-20. PubMed ID: 16456879
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Validation of multivariate outlier detection analyses used to identify potential drug-induced liver injury in clinical trial populations.
    Lin X; Parks D; Painter J; Hunt CM; Stirnadel-Farrant HA; Cheng J; Menius A; Lee K
    Drug Saf; 2012 Oct; 35(10):865-75. PubMed ID: 22928730
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Serological and pathological features of drug-induced liver injury and autoimmune hepatitis].
    Jiang ZL; Li P; Wang JL; Yang QH; Liu YG; Shi RF; Mi YQ
    Zhonghua Gan Zang Bing Za Zhi; 2016 Nov; 24(11):810-816. PubMed ID: 27978925
    [No Abstract]   [Full Text] [Related]  

  • 15. Propafenone-induced liver injury.
    Spinler SA; Elder CA; Kindwall KE
    Ann Pharmacother; 1992; 26(7-8):926-8. PubMed ID: 1354511
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Enhancing the utility of alanine aminotransferase as a reference standard biomarker for drug-induced liver injury.
    Ozer JS; Chetty R; Kenna G; Palandra J; Zhang Y; Lanevschi A; Koppiker N; Souberbielle BE; Ramaiah SK
    Regul Toxicol Pharmacol; 2010 Apr; 56(3):237-46. PubMed ID: 19903504
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical pattern of zileuton-associated liver injury: results of a 12-month study in patients with chronic asthma.
    Watkins PB; Dube LM; Walton-Bowen K; Cameron CM; Kasten LE
    Drug Saf; 2007; 30(9):805-15. PubMed ID: 17722971
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Spontaneous Fluctuations in Liver Biochemistries in Patients with Compensated NASH Cirrhosis: Implications for Drug Hepatotoxicity Monitoring.
    Shamseddeen H; Vilar-Gomez E; Chalasani N; Myers RP; Subramanian GM; Shlevin HH; Allgood AE; Orman ES
    Drug Saf; 2020 Mar; 43(3):281-290. PubMed ID: 31907854
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Drug-induced liver injury.
    Leise MD; Poterucha JJ; Talwalkar JA
    Mayo Clin Proc; 2014 Jan; 89(1):95-106. PubMed ID: 24388027
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anti-tuberculosis drug-induced liver injury in Shanghai: validation of Hy's Law.
    Shen X; Yuan Z; Mei J; Zhang Z; Guo J; Wu Z; Wu J; Zhang H; Pan J; Huang W; Gong H; Yuan D; Xiao P; Wang Y; Shuai Y; Lin S; Pan Q; Zhou T; Watkins PB; Wu F
    Drug Saf; 2014 Jan; 37(1):43-51. PubMed ID: 24203912
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.